Literature DB >> 32303282

It Takes Two to Tango: The Role of Dysregulated Metabolism and Inflammation in Kidney Disease Development.

Ghazal Z Quinn1, Poonam Dhillon1, Katalin Susztak2.   

Abstract

Acute kidney injury is a major contributor of chronic kidney disease development. The pathogenesis of acute kidney injury and chronic kidney disease shows significant similarities. Both conditions are associated with a defect in cellular metabolism, such as fatty acid oxidation and mitochondrial oxidative phosphorylation in kidney tubule cells and a marked increase in infiltrating immune cells. Here, we discuss how inflammatory cytokines and macrophages contribute to epithelial injury and metabolic defects. In addition, we discuss the role of mitochondrial damage and cytosolic leakage of the mitochondrial DNA activating the innate immune pathway such as cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon genes. The interplay between inflammation and metabolism appears to be critical for kidney disease development.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cGAS-STING; inflammation; innate immune system; kidney injury; metabolic dysregulation

Mesh:

Substances:

Year:  2020        PMID: 32303282      PMCID: PMC7682750          DOI: 10.1016/j.semnephrol.2020.01.010

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  56 in total

1.  PGC-1α Protects from Notch-Induced Kidney Fibrosis Development.

Authors:  Seung Hyeok Han; Mei-Yan Wu; Bo Young Nam; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Jihwan Park; Frank Chinga; Szu-Yuan Li; Katalin Susztak
Journal:  J Am Soc Nephrol       Date:  2017-07-27       Impact factor: 10.121

2.  Genomic integration of ERRγ-HNF1β regulates renal bioenergetics and prevents chronic kidney disease.

Authors:  Juanjuan Zhao; Katherine Lupino; Benjamin J Wilkins; Chengxiang Qiu; Jian Liu; Yasuhiro Omura; Amanda L Allred; Caitlin McDonald; Katalin Susztak; Grant D Barish; Liming Pei
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

Review 3.  Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.

Authors:  Y Guan; M D Breyer
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

4.  Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.

Authors:  Hyun Mi Kang; Seon Ho Ahn; Peter Choi; Yi-An Ko; Seung Hyeok Han; Frank Chinga; Ae Seo Deok Park; Jianling Tao; Kumar Sharma; James Pullman; Erwin P Bottinger; Ira J Goldberg; Katalin Susztak
Journal:  Nat Med       Date:  2014-12-01       Impact factor: 53.440

5.  Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.

Authors:  C Sassy-Prigent; D Heudes; C Mandet; M F Bélair; O Michel; B Perdereau; J Bariéty; P Bruneval
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

6.  PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.

Authors:  Ronak Lakhia; Matanel Yheskel; Andrea Flaten; Ezekiel B Quittner-Strom; William L Holland; Vishal Patel
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-13

Review 7.  Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

Authors:  Leonie K Heilbronn; Lesley V Campbell
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Transcriptome analysis of human diabetic kidney disease.

Authors:  Karolina I Woroniecka; Ae Seo Deok Park; Davoud Mohtat; David B Thomas; James M Pullman; Katalin Susztak
Journal:  Diabetes       Date:  2011-07-13       Impact factor: 9.461

9.  Complement C3 Produced by Macrophages Promotes Renal Fibrosis via IL-17A Secretion.

Authors:  Yanyan Liu; Kun Wang; Xinjun Liang; Yueqiang Li; Ying Zhang; Chunxiu Zhang; Haotian Wei; Ran Luo; Shuwang Ge; Gang Xu
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

10.  Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy.

Authors:  Karyne Pelletier; Arnaud Bonnefoy; Hugo Chapdelaine; Vincent Pichette; Matthieu Lejars; François Madore; Soumeya Brachemi; Stéphan Troyanov
Journal:  Kidney Int Rep       Date:  2019-03-20
View more
  3 in total

1.  Erythropoietin promotes energy metabolism to improve LPS-induced injury in HK-2 cells via SIRT1/PGC1-α pathway.

Authors:  Kan Li; Li Gao; Sen Zhou; Yan-Rong Ma; Xiao Xiao; Qian Jiang; Zhi-Hong Kang; Ming-Long Liu; Tian-Xi Liu
Journal:  Mol Cell Biochem       Date:  2022-08-24       Impact factor: 3.842

Review 2.  Emerging Insights Into Chronic Renal Disease Pathogenesis in Hypertension From Human and Animal Genomic Studies.

Authors:  Isha S Dhande; Michael C Braun; Peter A Doris
Journal:  Hypertension       Date:  2021-11-10       Impact factor: 10.190

3.  Activation of cGAS-STING pathway - A possible cause of myofiber atrophy/necrosis in dermatomyositis and immune-mediated necrotizing myopathy.

Authors:  Meichen Zhou; Xiaoxiao Cheng; Wenhua Zhu; Jianhua Jiang; Sijia Zhu; Xuan Wu; Meirong Liu; Qi Fang
Journal:  J Clin Lab Anal       Date:  2022-08-28       Impact factor: 3.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.